Trial reportScientific reports2025
Relationship between dementia diagnostic characteristics and severity of depressive symptoms in a cross-sectional analysis of HOMESIDE baseline data.
Trial report in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03907748 (HOMESIDE), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
HOMESIDE: Home-based Family Caregiver-delivered Music and Reading Interventions for People Living With Dementia: A Randomised Controlled Trial
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Depression is a common comorbidity in dementia, with prevalence ranging from 20 to 60% across different countries. This study examined whether depressive symptom severity levels differ by dementia characteristics and country of residence in people living with dementia. This cross-sectional analysis used baseline data from 376 participants in the HOMESIDE trial. Linear regression models examined differences in depressive symptom severity levels by dementia stage, type, severity, and country. In this sample (57% male, mean age 76.6 years), depressive symptom scores were higher for people with severe cognitive impairment than those with mild dementia (MMSE 24-30) (adjusted mean difference: 3.78, 95% CI 1.60-5.96). Mean depressive symptom severity was lower in Norway, Germany, and United Kingdom compared to Australia, with no significant difference for Poland. No apparent differences by dementia type or stage were found. Depressive symptom severity levels differed by cognitive impairment severity and country. Cross-national differences likely reflect a complex interplay of healthcare systems, cultural factors, family support structures, and societal approaches to dementia care. Regular depressive symptom screening is recommended, particularly for severe dementia.Trial registration: ACTRN12618001799246 (Australian New Zealand Clinical Trials Registry) and NCT03907748 (ClinicalTrials.gov).
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.